Home Other Building Blocks 398507-55-6
398507-55-6,MFCD21363826
Catalog No.:AA00C9DN

398507-55-6 | Lodenafil carbonate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
1 week  
$924.00   $647.00
- +
5mg
98%
1 week  
$1,606.00   $1,124.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00C9DN
Chemical Name:
Lodenafil carbonate
CAS Number:
398507-55-6
Molecular Formula:
C47H62N12O11S2
Molecular Weight:
1035.1990
MDL Number:
MFCD21363826
SMILES:
CCCc1nn(c2c1nc([nH]c2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)CCOC(=O)OCCN1CCN(CC1)S(=O)(=O)c1ccc(c(c1)c1nc2c(CCC)nn(c2c(=O)[nH]1)C)OCC)C
Properties
Computed Properties
 
Complexity:
2020  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
72  
Hydrogen Bond Acceptor Count:
19  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
22  
XLogP3:
3  

Literature

Title: Development and validation of a stability-indicating LC method for the assay of lodenafil carbonate in tablets.

Journal: Journal of chromatographic science 20110801

Title: The management of erectile dysfunction: innovations and future perspectives.

Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20110301

Title: Efficacy and tolerability of lodenafil carbonate for oral therapy of erectile dysfunction: a phase III clinical trial.

Journal: The journal of sexual medicine 20100501

Title: Cardiovascular repercussion of lodenafil carbonate, a new PDE5 inhibitor, with and without alcohol consumption.

Journal: Arquivos brasileiros de cardiologia 20100201

Title: Efficacy and tolerability of lodenafil carbonate for oral therapy in erectile dysfunction: a phase II clinical trial.

Journal: The journal of sexual medicine 20090201

Title: Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum.

Journal: European journal of pharmacology 20080904

Title: Glina S, et al. Efficacy and tolerability of lodenafil carbonate for oral therapy in erectile dysfunction: a phase II clinical trial. J Sex Med. 2009 Feb;6(2):553-7.

Title: Toque HA, et al. Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum. Eur J Pharmacol. 2008 Sep 4;591(1-3):189-95.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:398507-55-6 Molecular Formula|398507-55-6 MDL|398507-55-6 SMILES|398507-55-6 Lodenafil carbonate